Skip to main content

Horizon Therapeutics Public Ltd Co

HZNPDelisted Oct 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001492426

Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q2 2023

Institutional positions in Horizon Therapeutics Public Ltd Co as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
516
−31 vs. Q1 2023
Shares held
211.5M
+6.37M (+3.1%) vs. Q1 2023
Total value
$21.7B
−$716.0M (−3.2%) vs. Q1 2023
New holders
51
160 more added
Sold out
82
208 more reduced

5 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HZNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 516 institutions
Q1 2021: 516 institutionsQ2 2021: 527 institutionsQ3 2021: 571 institutionsQ4 2021: 609 institutionsQ1 2022: 618 institutionsQ2 2022: 615 institutionsQ3 2022: 528 institutionsQ4 2022: 611 institutionsQ1 2023: 552 institutionsQ2 2023: 516 institutionsQ3 2023: 483 institutionsQ4 2023: 6 institutionsQ1 2024: 1 institutionQ2 2024: 2 institutionsQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ2 2023: $21.7B
Q1 2021: $18.4BQ2 2021: $18.9BQ3 2021: $22.2BQ4 2021: $22.0BQ1 2022: $21.8BQ2 2022: $16.5BQ3 2022: $13.0BQ4 2022: $23.8BQ1 2023: $22.5BQ2 2023: $21.7BQ3 2023: $24.8BQ4 2023: $49.4KQ1 2024: $116Q2 2024: $3.95KQ3 2024: $116Q4 2024: $116Q1 2025: $116Q2 2025: $116Q3 2025: $116Q4 2025: $116Q1 2026: $116Q2 2026: $116
Institutions holding HZNP and their total value by quarter
QuarterHoldersValue
Q2 20261$116
Q1 20261$116
Q4 20251$116
Q3 20251$116
Q2 20251$116
Q1 20251$116
Q4 20241$116
Q3 20241$116
Q2 20242$3.95K
Q1 20241$116
Q4 20236$49.4K
Q3 2023483$24.8B
Q2 2023516$21.7B
Q1 2023552$22.5B
Q4 2022611$23.8B
Q3 2022528$13.0B
Q2 2022615$16.5B
Q1 2022618$21.8B
Q4 2021609$22.0B
Q3 2021571$22.2B
Q2 2021527$18.9B
Q1 2021516$18.4B

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Horizon Therapeutics Public Ltd Co; share changes are against Q1 2023.

Institutions holding HZNP in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Householder Group Estate & Retirement Specialist, LLC––––Not filed
Ahrens Investment Partners LLC––––Not filed
Harvest Group Wealth Management, LLC––––Not filed